FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

425753008: Conventional release cutaneous ointment (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661903018 Cutaneous ointment (qualifier value) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
2675419011 Topical ointment en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
2675420017 Cutaneous ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3541117017 Conventional release cutaneous ointment (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3541118010 Conventional release cutaneous ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
230051000052116 kutan salva sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous ointment Is a kutan och/eller transdermal läkemedelsform false Inferred relationship Some
Cutaneous ointment Is a Ointment false Inferred relationship Some
Cutaneous ointment Is a Cutaneous dose form true Inferred relationship Some
Cutaneous ointment Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Cutaneous ointment Has dose form intended site (attribute) Cutaneous (intended site) true Inferred relationship Some
Cutaneous ointment Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Cutaneous ointment Has basic dose form (attribute) Ointment true Inferred relationship Some
Cutaneous ointment Has dose form transformation (attribute) No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Retapamulin 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Sodium fusidate 20 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
takalcitol (som takalcitolmonohydrat) 4 mikrogram/gram, kutan salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
salicylsyra 60 % i vitt mjukt paraffin 40 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
klortetracyklinhydroklorid 3 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Nystatin 100000 unit/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
gentamicinsulfat 0,1 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Nystatin 100 unit/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
erytromycin 20 mikrogram/milligram, kutan salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Bacitracin 500 unit/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Prednicarbate 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
mikonazol 0,25 % / zinkoxid 15 % / vitt vaselin 81,35 %, salva för lokalt bruk Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
katekin 15 %, salva för lokalt bruk Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Dithranol 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
kamomillextrakt 10,5 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone acetate 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
betametason 0,1 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
betametason (som betametasondipropionat) 500 nanogram/milligram, kutan salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Clobetasone butyrate 500 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Diflucortolone valerate 3 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
fluokortolon 0,5 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Mometasone furoate 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Fluticasone propionate 50 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Lithium succinate 80 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Povidone iodine 100 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Clobetasol propionate 500 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone 5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Neomycin 5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Cinchocaine 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
betametasondipropionat 0,5 mg/g, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Triamcinolone acetonide 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Fludroxycortide 250 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Fludroxycortide 500 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Amcinonide 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Desonide 500 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Halcinonide 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Desoximetasone 2.5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone valerate 2 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Erythromycin 5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
betametasondipropionat 0,5 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Aciclovir 50 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
lidokain 5 % + hydrokortisonacetat 0,275 %, salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
takrolimus (som takrolimusmonohydrat) 300 mikrogram/gram, kutan salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
takrolimus (som takrolimusmonohydrat) 1 milligram/gram, kutan salva Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
lidokain 2,5 %, salva för lokalt bruk Has manufactured dose form False Cutaneous ointment Inferred relationship Some
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Tetracycline 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Lidocaine hydrochloride 25 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely betamethasone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Crisaborole 20 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Tirbanibulin 10 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely tacalcitol 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Lysine hydrochloride 150 mg/g cutaneous ointment Has manufactured dose form True Cutaneous ointment Inferred relationship Some
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Cutaneous ointment Inferred relationship Some

Page 1 of 2 End

This concept is not in any reference sets

Back to Start